期刊文献+

丙戊酸钠诱导肝癌细胞HepG2凋亡及其机制探讨 被引量:2

Effects and mechanisms of VPA on cell apoptosis in the human hepotoma cell-HepG2
下载PDF
导出
摘要 目的观察丙戊酸钠对肝癌细胞系HepG2的诱导凋亡作用并通过检测Caspase3、Caspase8、Caspase9的活性及蛋白表达探讨其诱导凋亡的机制。方法经0.75~4.0mmol/L丙戊酸钠诱导后,流式细胞仪Annexin V/PI双标法分析细胞凋亡的变化;分光光度法检测Caspase3、Caspase8、Caspase9活性;流式细胞仪间接免疫荧光法定量分析Caspase3、Caspase8、Caspase9蛋白表达。结杲丙戊酸钠可明显诱导HepG2细胞凋亡,并且此作用呈时间、剂量依赖趋势;经过丙戊酸钠诱导,Caspase3、Caspase9活性及蛋白表达被上调,较对照组明显升高(P〈0.001),Caspase8活性及蛋白表达未见明显改变(P〉0.05)。结论丙戊酸钠可明显诱导HepG2肝癌细胞凋亡,此作用通过激活内源性凋亡途径实现。 Objective To investigate the effects of Valproate acid sodium(VPA), a selective inhibitor of HDACs, on cell apoptosis of the human hepotoma cell -HepG2 and study the probable mechanisms. Methods The apoptosis rate was determined by FCM with Annexin V/PI staining. The activities and protein expressions of Caspase3, Caspase8 and Caspase9 were determined by spectrophotometry and indirect immunofluorescence techniques. Results After treatment with different concentrations of VPA, the apoptosis rate of human hepotoma cells significantly increased in a time- and dose-dependent manner. The activities and protein expressions of Caspase3 and Caspase9 were up-regulated in the exper- imental group compared with the control group ( P 〈 0.001 ). On the other hand, both the activity and the protein expression of Caspase8 were not significantly different between the experimental group and the control group ( P 〉 0.05). Conclusion VPA can effectively induce HepG2 cell apoptosis by activating the intrinsic apoptosis pathway.
出处 《山东大学学报(医学版)》 CAS 北大核心 2007年第12期1239-1242,共4页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金项目(2004ZX06) 山东省卫生科技发展计划青年基金项目
关键词 肝肿瘤 肝癌细胞系 凋亡 半胱氨酸天冬氨酸酶 Hepetoma HepG2 Apeptosis Caspase
  • 相关文献

参考文献10

  • 1Choi J H, Kwon H J, Yoon B I, et al. Expression profile of histone deacetylase in gastric cancer tissues[J]. Jpn J Cancer Res, 2001, 92(12) : 13130-1304.
  • 2Redner R L, Wang J, Liu J M. Chromatin remodeling and leukemia: new therapeutic paradigms[J]. Blood, 1999, 94 (2) :417-428.
  • 3Marks P A, Rifkind R A, Richon V M, et al. Histone deacetylases and cancer: causes and therapies[J]. Nature, 2001, 1 (3) : 194-202.
  • 4Turner B M. Cellular memory and the histone code[J]. Cell, 2002, 111(3): 285-291.
  • 5Gillenwater A, Zou C P, Zhong M, et al. Effect of sodium butyrate on growth, differentiation and apoptosis in head and neck squamous carcinoma cell fines[J]. Head Neck, 2000, 22(3) :247-256.
  • 6Known S H, Ahn S H, Kim Y K, et al. Apicidin, a histone deacetylase inhibitor, induces apoptosis and FAS/FAS ligand expression in human acute promielocytic leukemia cells[J]. J Biol Chem, 2002, 277(3):2073-2080.
  • 7Vrana J A, Decker R H, Johnson C R, et al. Induction of apoptosis in U937 human leukemia cells by superoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by BCL-2/BCL-XL, c-JUN and p21CIP, but independent of p53[J]. Oncogene, 1999, 18(50):7016-7025.
  • 8Aron J L, Parthun M R, Marucci G, et al. Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cell concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein [ J ]. Blood, 2003, 102 (2) : 652-658.
  • 9Yang H, Hoshino K, Sanehez-Gonzalez B, et al. Antileukemia activity of the combination of 5-aza-2'-deoxyeytidine with valproic acid[J]. Leuk Res, 2005, 29(7):739-748.
  • 10Rocchi P, Tonelli R, Camerin C, et al. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valpmic acid, tributyrin and sodium butyrate) in neuroblastoma cells[J]. Oncol Rep, 2005, 13(6) : 1139- 1144.

同被引文献14

  • 1许沈华,余传定,牟瀚舟,姜志明,朱赤红,刘祥麟.用基因芯片筛选胃黏膜癌变相关基因[J].中华胃肠外科杂志,2006,9(5):436-440. 被引量:6
  • 2李攀,赵春景.美洛昔康对人肝癌HepG_2细胞增殖的抑制作用[J].中国药房,2007,18(10):744-746. 被引量:2
  • 3时昌文,李杰,赵霞,曹莉莉,孙京杰.丙戊酸钠对肝癌细胞系HepG2的生长抑制作用[J].中华肿瘤防治杂志,2007,14(7):510-513. 被引量:12
  • 4Turner B M. Cellular memory and the histone code[J]. Cell,2002, 111(3): 285 -291.
  • 5ChoiJ H, Kwon H J, Yoon BI, et al. Expression profile of his tone deacetylase in gastric cancer tissues[J]. Jpn J Cancer Res, 2001, 92(12):1300-1304.
  • 6Kim M S, Son M W, Kim W B,et al. Apicidin, an inhibitor of histone deacetylase, prevents H-ras-induced invasive phenotype [J]. Cancer Lett,2000,157(1):23-30.
  • 7Qian D Z, Wang X, Kachhap S K, et at. The histone cleacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ ZK222584[J]. Cancer Res, 2004, 64(18) :6626-6634.
  • 8Johnstone RW, Licht JD. Histone deacetylase inhibitors in cancer therapy: Is transcription the primary target[J]. Cancer Cell, 2003, 4(1): 13.
  • 9Atadja P, Gao L, Kwon P, et al. Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824[J]. Cancer Res, 2004, 64 (2) : 689.
  • 10Marks PA, Richon VM, Miller T, et al. Histone deacetylase inhibitors[J], Adv Cancer Res, 2004, 91 : 137.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部